Istituto Oncologico Veneto Irccs

This early-phase study tested adding the drug regorafenib to standard treatment (temozolomide with or without radiation) for people newly diagnosed with a specific type of aggressive brain cancer called MGMT-methylated glioblastoma. The main goal was to find the safest dose of re…

This phase 3 trial tested whether adding the immunotherapy drug avelumab after standard treatment (surgery and chemotherapy) helps prevent cancer from coming back in people with high-risk triple negative breast cancer. The study enrolled 474 adults who had already completed curat…

This study observed 100 older adults (age 70+) with advanced kidney cancer to see how safe and effective the drug Cabozantinib is. The main goal was to track side effects. The study was completed, but it was observational, meaning it just watched what happened without giving a ne…

This study looked back at over 1000 cases of two rare, non-invasive breast conditions called florid and pleomorphic lobular carcinoma in situ. The goal was to understand how doctors currently diagnose and treat them, since there are no standard guidelines. By analyzing what treat…